These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31099095)

  • 21. Acute radiotherapy toxicity in 57 dogs with gross and microscopic mast cell tumours.
    Blackwood L; Tanis JB; Harper A; Amores-Fuster I; Killick DR; Finotello R
    Vet Comp Oncol; 2018 Dec; 16(4):431-440. PubMed ID: 29761612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival with stereotactic radiotherapy for imaging-diagnosed pituitary tumors in dogs.
    Hansen KS; Zwingenberger AL; Théon AP; Kent MS
    Vet Radiol Ultrasound; 2019 Mar; 60(2):219-232. PubMed ID: 30575174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer.
    Faria SL; Souhami L; Portelance L; Duclos M; Vuong T; Small D; Freeman CR
    Radiat Oncol; 2006 Nov; 1():42. PubMed ID: 17078878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External-beam Co-60 radiotherapy for canine nasal tumors: a comparison of survival by treatment protocol.
    Yoon JH; Feeney DA; Jessen CR; Walter PA
    Res Vet Sci; 2008 Feb; 84(1):140-9. PubMed ID: 17950765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
    Singh AK; Lockett MA; Bradley JD
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):337-41. PubMed ID: 12527046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-escalated Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer.
    Kim JO; Chu KP; Fairchild A; Ghosh S; Butts C; Chu Q; Gabos Z; Joy AA; Nijjar T; Robinson DM; Sangha R; Scrimger R; Smylie M; Yee D; Roa WH
    Am J Clin Oncol; 2017 Jun; 40(3):294-299. PubMed ID: 25333733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma.
    Kung MBJ; Poirier VJ; Dennis MM; Vail DM; Straw RC
    Vet Comp Oncol; 2016 Dec; 14(4):e135-e145. PubMed ID: 25393921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.
    Baumann R; Koncz M; Luetzen U; Krause F; Dunst J
    Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.
    Tekatli H; Duijm M; Oomen-de Hoop E; Verbakel W; Schillemans W; Slotman BJ; Nuyttens JJ; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):738-747. PubMed ID: 29413285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation-induced osteosarcoma in dogs after external beam or intraoperative radiation therapy.
    Gillette SM; Gillette EL; Powers BE; Withrow SJ
    Cancer Res; 1990 Jan; 50(1):54-7. PubMed ID: 2403417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional conformal radiation therapy for canine aortic body tumour: 6 cases (2014-2019).
    Maeda A; Murakami M; Iwasaki R; Goto S; Kitagawa K; Sakai H; Mori T
    J Small Anim Pract; 2021 May; 62(5):385-390. PubMed ID: 33300156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicity and outcome in cats with oral squamous cell carcinoma after accelerated hypofractionated radiotherapy and concurrent systemic treatment.
    Marconato L; Weyland M; Tresch N; Rossi F; Leone V; Rohrer Bley C
    Vet Comp Oncol; 2020 Sep; 18(3):362-369. PubMed ID: 31756259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy effects on brain/bone metastatic adenocarcinoma lung cancer and the importance of EGFR mutation test.
    Qu BL; Cai BN; Yu W; Liu F; Huang YR; Ju ZJ; Wang XS; Ou GM; Feng LC
    Neoplasma; 2016; 63(1):158-62. PubMed ID: 26639246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
    Palumbo I; Mariucci C; Falcinelli L; Perrucci E; Lancellotta V; Podlesko AM; Marcantonini M; Saldi S; Bini V; Aristei C
    Breast Cancer; 2019 May; 26(3):290-304. PubMed ID: 30341747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.
    Pollom EL; Qian Y; Durkee BY; von Eyben R; Maxim PG; Shultz DB; Gensheimer M; Diehn M; Loo BW
    Clin Lung Cancer; 2016 Nov; 17(6):588-594. PubMed ID: 27378172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative radiotherapy for canine soft tissue sarcoma.
    Forrest LJ; Chun R; Adams WM; Cooley AJ; Vail DM
    J Vet Intern Med; 2000; 14(6):578-82. PubMed ID: 11110377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.